ANI PHARMACEUTICALS INC — Director's Dealing 2015

Apr 20, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2015-04-16

Reporting Person: MARSHBANKS TRACY (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-04-16	Common Stock	A	800	—	Acquired	9110	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-04-16	Option to Purchase	$68.71	A	1600	Acquired	2025-04-15	Common Stock (1600)	Direct

Footnotes

F1: On April 16, 2015, the Board of Directors of the Issuer approved the grant of restricted stock, which vest on the first anniversary of the grant date.

F2: The closing price of the Issuer's common stock on the NASDAQ Global Market on the grant date.